Insider transaction details
A director at AXT Inc. sold 30,832 shares of the company's common stock on March 10, 2026, reporting proceeds of $1,405,908. The shares changed hands at weighted average prices ranging from $44.52 to $46.63 per share.
Stock context and current trading
The timing of the sale coincides with a dramatic move in the equity - the stock has gained 2,860% over the past 12 months and is trading at $49.21, near its 52-week high of $47.94. The combination of a large year-over-year increase and prices close to the reported 52-week peak provides context for the director's disposition.
Remaining holdings
Despite the sale, Young Morris S. continues to hold a substantial indirect position. Ownership through the Young Family Trust DTD stands at 2,313,233 shares, a stake the filing values at $2.62 billion.
Company guidance revision
Separately, AXT Inc. trimmed its revenue guidance for the fourth quarter of 2025. The updated forecast calls for revenue between $22.5 million and $23.5 million, down from the prior range of $27 million to $30 million. The company attributed the shortfall to a reduced number of export permits for indium phosphide substrates issued by China’s Ministry of Commerce, which has limited AXT's ability to fulfill certain customer orders.
Analyst reactions
Market observers have issued contrasting takes on AXT's position. Craig-Hallum raised its price target to $26.00, pointing to strong demand and potential supply constraints among competitors resulting from China’s indium export policies. By contrast, B. Riley downgraded the stock to Neutral, citing valuation concerns even as it lifted its price target to $18.00.
Sector notes and related analyst activity
In related coverage of the semiconductor equipment ecosystem, Needham upgraded Nova Measuring Instruments to Buy, applauding its global execution and potential upside from China’s memory wafer fabrication equipment market by 2026. Needham also upgraded Ichor Holdings to Buy, describing it as a potential derivative play tied to larger semiconductor equipment manufacturers.
Research and premium content
The filing notes that InvestingPro subscribers can access 18 additional ProTips for AXTI as well as a comprehensive Pro Research Report that reviews the company’s volatile price movements and growth prospects.
Summary perspective
The insider sale, sizeable residual trust holdings, the company's lowered revenue guidance tied to export-permit constraints, and mixed analyst reactions together frame AXT's near-term outlook as one shaped by supply-chain permissioning and valuation debate.
Key points
- Director Young Morris S. sold 30,832 shares on March 10, 2026, for $1,405,908 at weighted average prices of $44.52 to $46.63 per share.
- AXT reduced Q4 2025 revenue guidance to $22.5 million - $23.5 million, citing fewer export permits for indium phosphide substrates from China’s Ministry of Commerce, which affected order fulfillment.
- Analysts are split - Craig-Hallum raised its target to $26 citing strong demand and potential supply constraints, while B. Riley downgraded to Neutral despite raising its target to $18; Needham upgraded two related equipment suppliers.
Risks and uncertainties
- Export-permit issuance - Reduced permits for indium phosphide substrates from China’s Ministry of Commerce have already impacted AXT’s ability to meet customer orders; this regulatory factor remains a direct operational risk for the semiconductor materials supply chain.
- Valuation sensitivity - With the stock up 2,860% over the past year and trading near reported highs, valuation concerns cited by B. Riley present a market-risk factor for investors and could influence future analyst positioning and investor sentiment.
- Order fulfillment and supply constraints - Continued limits on access to critical substrates could constrain production across the semiconductor supply chain and affect related equipment and materials suppliers.